Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.00
Bid: 15.50
Ask: 16.50
Change: 0.25 (1.59%)
Spread: 1.00 (6.452%)
Open: 15.75
High: 16.00
Low: 15.75
Prev. Close: 15.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix Health gets approval to sell products in Saudi Arabia

Mon, 24th Oct 2022 13:41

(Alliance News) - OptiBiotix Health PLC on Monday said its exclusive distributor Nahdi Medical Co has received approval from the Saudi Food and Drug authority.

The York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions said the approval is for its GoFigure shakes and bars, which contain patented weight management aid SlimBiome.

The GoFigure range of products consists of powdered meal replacement and beverage products such as shakes and smoothies, and healthy snacking including gummies and so on.

OptiBiotix said the approval is a "milestone to marketing and selling the products through pharmacies of Nahdi in Saudi Arabia".

The firm said it has now received the first purchase order from Nahdi and begun manufacturing. It expects the launch in first quarter next year.

Chief Executive Officer Rene Kamminga said: "I am very pleased the regulatory approval process is now complete and that we can now focus on getting the GoFigure range direct to the Saudi consumer. The GoFigure range has been specifically formulated to support consumers aiming to reduce their weight, help them stick to their change in diet and improve their gut microbiome at the same time. This particular range has been adapted specifically to fit the consumer preferences in Saudi Arabia and we are confident that we can build lasting success with our partner Nahdi."

OptiBiotix said it signed an exclusive sales and marketing deal with Nahdi last December, who owns the largest pharmacy network in Saudi Arabia.

Shares were up 2.3% at 17.90 pence each on Monday afternoon in London.

By Xindi Wei; xindiwei@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
20 May 2019 10:45

OptiBiotix inks deal with Nutrilinea for hypertension supplement

(Sharecast News) - Life sciences company OptiBiotix Health announces on Monday that its wholly-owned subsidiary ProBiotix Health has signed a license agreement with Nutrilinea for the use of its 'LPLDL' product in a food supplement for the reduction of high blood pressure, or hypertension.

Read more
7 May 2019 12:13

OptiBiotix inks LPLDL deal with Spain's IENP

(Sharecast News) - Life sciences business OptiBiotix Health announced on Tuesday that its wholly-owned subsidiary ProBiotix Health has signed a license agreement with Instituto EspaƱol de NutriciĆ³n Personalizada (IENP) for the use of 'lactobacillus plantarum' (LPLDL) in personalised food supplements in Spain.

Read more
29 Apr 2019 13:04

OptiBiotix Expects Further Growth After Annual Revenue Multiplies

LONDON (Alliance News) - OptiBiotix Health PLC on Monday reported a significant growth in revenue in its most recently ended financial year as it is on track to become a commercial life sciences a

Read more
24 Apr 2019 11:28

OptiBiotix to launch SlimBiome Medical in UK market this month

(Sharecast News) - Life sciences business OptiBiotix Health announced the launch of its weight management product 'SlimBiome Medical' to the UK market on Wednesday.

Read more
11 Apr 2019 11:16

OptiBiotix partner gets approval to make SlimBiome in India

(Sharecast News) - OptiBiotix Health announced on Thursday that it has received a licence from the Food Standards and Safety Authority India (FSSAI) for its weight management product 'SlimBiome' to be manufactured in the country.

Read more
9 Apr 2019 09:58

OptiBiotix Inks SlimBiome Distribution Pact For Bulgaria

LONDON (Alliance News) - OptiBiotix Health PLC on Tuesday said it has entered into a three-year deal with an undisclosed company to distribute and commercialise SlimBiome Medical in is used for a

Read more
20 Mar 2019 07:41

OptiBiotix inks deal with DKSH for Italy and Spain markets

(Sharecast News) - Life sciences company OptiBiotix Health has entered into an exclusive agreement with DKSH International to distribute its 'SlimBiome' proprietary weight management technology in Italy and Spain, it announced on Wednesday.

Read more
15 Mar 2019 08:16

Optibiotix Health expands international reach through supply agreement

(Sharecast News) - OptiBiotix Health on Friday extended a supply agreement to broaden the supply of cholesterol-lowering capsules into Germany and several other countries.

Read more
13 Mar 2019 16:08

OptiBiotix Health Secures GBP57,000 Following Warrants Exercise (ALLISS)

LONDON (Alliance News) - OptiBiotix Health PLC on Wednesday said it has raised GBP56,666 following an exercise of warrants.The life sciences company said 708,325 warrants were exercised at

Read more
21 Feb 2019 11:38

US FDA Finds OptiBiotix Health Cholesterol Probiotic Safe For Use

LONDON (Alliance News) - OptiBiotix Health PLC on Thursday said the US FDA assigned a GRAS designation to its cholesterol and blood pressure reducing probiotic strain.The Lactobacillus by a

Read more
21 Feb 2019 11:07

OptiBiotix up as LPLDL gets 'safe' status in US

(Sharecast News) - Life sciences firm OptiBiotix Health confirmed on Thursday that its wholly-owned subsidiary ProBiotix Health has had its cholesterol and blood pressure reducing 'Lactobacillus plantarum LPLDL' probiotic strain determined as 'Generally Recognized As Safe' (GRAS) by an independent expert GRAS panel in the United States.

Read more
13 Feb 2019 08:46

Optibiotix revenues soar in second half

(Sharecast News) - Optibiotix Health's annual income soared in its last trading year as the healthy food additive maker continued to commercialise its products and grow sales.

Read more
11 Feb 2019 12:32

OptiBiotix gains foothold in Japan with distibution deal

(Sharecast News) - Optibiotix Health on Monday signed an agreement appointing EIWA Trading Co. as its exclusive distributor for its cholesterol and blood pressure-reducing probiotic strain LPLDL in Japan.

Read more
11 Feb 2019 10:03

OptiBiotix Health Appoints EIWA To Distribute LPLDL Products In Japan

LONDON (Alliance News) - Life sciences company Optibiotix Health PLC said on Monday it has appointed EIWA Trading Co Ltd as the exclusive distributor for its LPLDL products in Japan.In EIWA

Read more
7 Feb 2019 10:40

OptiBiotix Health Inks Commercial Deal Covering Baltics With Biolat

LONDON (Alliance News) - OptiBiotix Health PLC on Thursday said it has entered a three-year supply agreement with Latvia-based firm Biolat JSC covering Estonia, Latvia and is a life sciences firm

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.